Cyxone’s executive management team consists of experienced experts with solid knowledge in the fields of drug development, business development and financing in innovative biotech companies.
Born 1970. CEO since 2022.
Carl-Magnus Högerkorp holds a PhD in immunology from Lund University, as well as an MBA from EFL/Lund school of Economics and Management. He brings long and broad experience from pharma and biotech companies, both internationally and nationally. During his career, Dr Högerkorp has for example worked with research and development projects within infectious disease, immuno oncology, regenerative medicine, inflammation and autoimmune diseases. Further, he has held senior positions in several companies such as CEO for Edvince, Canimguide Therapeutics and ImModulate Pharma and CSO at Xintela, where he took part in the introduction of the company on Nasdaq First North Growth Market.
Carl-Magnus Högerkorp owns 181,673 shares in Cyxone
Born 1961. CFO since 2023.
Malin has studied Business and Administration program at Lund University with a focus on Business Law and Organization and Leadership. She has several years of experience as Controller and office Manager in public biotech companies such as Gabather AB.
Born 1976. CDO since 2022.
Erika Samuelsson holds a PhD in Immunology from Lund University and has over 20 years’ experience from the Life Science field. Erika has held senior positions at Alligator Bioscience AB, Idogen AB and most recently at Immunovia AB. She brings long experience within drug development where she has been responsible for studies in both late and early development stages. She also has extensive experience within Business Development, Alliance management and strategic communication in listed companies.
CEO assistant/Office Manager
Rhea Rodeo has many years of work experience as HR assistant, Secretary, Administrator, and Project Administrator. Before joining Cyxone, she worked at large international companies in Sweden, such as Westinghouse and IKEA. At Cyxone, Rhea Rodeo is responsible for general administration and provides support and assistance to the CEO and CFO.
Phone: +46 708 88 21 72